Fluspirilene (Imap) in the treatment of psychosomatic complaints in hypochondriacal patients.

Patients with psychosomatic complaints of a hypochondriacal nature were treated with a weekly IM dose of 1.2-1.5 mg fluspirilene (0.6-0.75 ml IMAP) for a period of 10 weeks. According to the physicians' ratings, good results were obtained in 58%, moderate ones in 28%. In the patients' ratings, this corresponded to 60 and 26% respectively. Acceptability of the treatment was assessed as good by 88% of the physicians and 90% of the patients. Only two side effects were reported by three patients alike (dry mouth and sweating). The other side-effects were rarer in occurrence and half of them were transient.